Log in to save to my catalogue

Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography-Tandem Mass Spectrometry: C...

Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography-Tandem Mass Spectrometry: C...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2353578360

Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography-Tandem Mass Spectrometry: Current State and Future Vision

About this item

Full title

Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography-Tandem Mass Spectrometry: Current State and Future Vision

Publisher

England: American Association for Clinical Chemistry, Inc

Journal title

Clinical chemistry (Baltimore, Md.), 2020-02, Vol.66 (2), p.282-301

Language

English

Formats

Publication information

Publisher

England: American Association for Clinical Chemistry, Inc

More information

Scope and Contents

Contents

Immunoaffinity-mass spectrometry (IA-MS) is an emerging analytical genre with several advantages for profiling and determination of protein biomarkers. Because IA-MS combines affinity capture, analogous to ligand binding assays (LBAs), with mass spectrometry (MS) detection, this platform is often described using the term hybrid methods. The purpose...

Alternative Titles

Full title

Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography-Tandem Mass Spectrometry: Current State and Future Vision

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2353578360

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2353578360

Other Identifiers

ISSN

0009-9147

E-ISSN

1530-8561

DOI

10.1093/clinchem/hvz022

How to access this item